相似文献
1
CABG versus PCI: What is the optimal strategy for multi-vessel disease?冠状动脉搭桥术与经皮冠状动脉介入治疗：多支血管病变的最佳策略是什么？
Ann Med Surg (Lond). 2022 Aug 18;81:104354. doi: 10.1016/j.amsu.2022.104354. eCollection 2022 Sep.
2
Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI.306868例多支冠状动脉疾病患者的长期死亡率：冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较
Br J Med Med Res. 2013 Oct;3(4):1248-1257. doi: 10.9734/bjmmr/2013/3380.
3
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.多支冠状动脉疾病患者冠状动脉搭桥术与药物洗脱支架经皮冠状动脉介入治疗的疗效比较
Circulation. 2007 Sep 11;116(11 Suppl):I200-6. doi: 10.1161/CIRCULATIONAHA.106.681148.
4
Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.对于既往接受冠状动脉旁路移植术（CABG）的患者，在二次经皮冠状动脉介入治疗（PCI）后，使用自身血管进行PCI与使用移植血管进行PCI相比，长期预后更佳。
Int J Cardiol. 2017 Feb 1;228:563-569. doi: 10.1016/j.ijcard.2016.11.031. Epub 2016 Nov 14.
5
Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey.心肌梗死、多支冠状动脉疾病和心源性休克患者的冠状动脉血运重建和循环支持策略：国际调查的见解。
Am Heart J. 2020 Jul;225:55-59. doi: 10.1016/j.ahj.2020.04.011. Epub 2020 May 3.
6
Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).多血管冠状动脉血运重建患者行经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较（来自 CREDO-Kyoto PCI/CABG 注册研究/队列研究 2）。
Catheter Cardiovasc Interv. 2020 Jul;96(1):42-51. doi: 10.1002/ccd.28420. Epub 2019 Aug 7.
7
Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetic patients with multi-vessel coronary disease: a meta-analysis.经皮冠状动脉介入治疗（PCI）与冠状动脉旁路移植术（CABG）治疗多支血管病变糖尿病患者的疗效比较：一项荟萃分析。
Diabetes Res Clin Pract. 2012 Aug;97(2):178-84. doi: 10.1016/j.diabres.2012.03.020. Epub 2012 Apr 16.
8
Ten-year improved survival in patients with multi-vessel coronary disease and poor left ventricular function following surgery: A retrospective cohort study.多支冠状动脉病变伴左心室功能不良患者手术后 10 年生存率的提高：一项回顾性队列研究。
Int J Surg. 2020 Apr;76:146-152. doi: 10.1016/j.ijsu.2020.03.008. Epub 2020 Mar 13.
9
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.三血管病变或左主干病变患者完全血运重建后十年全因死亡情况：来自 SYNTAX 扩展生存研究的结果。
Circulation. 2021 Jul 13;144(2):96-109. doi: 10.1161/CIRCULATIONAHA.120.046289. Epub 2021 May 20.
10
Stent versus Coronary Artery Bypass Surgery in Multi-Vessel and Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Trials with Subgroups Evaluation.支架置入术与冠状动脉旁路移植术治疗多支血管病变和左主干冠状动脉疾病：随机试验的荟萃分析与亚组评估。
Arq Bras Cardiol. 2019 May;112(5):511-523. doi: 10.5935/abc.20190027. Epub 2019 Feb 21.
引用本文的文献
1
Return to work after coronary artery bypass graft surgery and investigation of its effects on patient.冠状动脉搭桥手术后重返工作岗位及其对患者影响的调查
BMC Public Health. 2025 Aug 14;25(1):2781. doi: 10.1186/s12889-025-24155-4.
本文引用的文献
1
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率：一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
2
Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials.在多支血管病变中，冠状动脉搭桥手术优于药物洗脱支架。当代随机对照试验的系统评价和荟萃分析。
Int J Cardiol. 2016 May 1;210:19-24. doi: 10.1016/j.ijcard.2016.02.090. Epub 2016 Feb 18.
3
Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.药物洗脱支架经皮冠状动脉介入治疗与多支冠状动脉疾病患者冠状动脉旁路移植术的比较：六项随机对照试验的荟萃分析
Cardiovasc Revasc Med. 2015 Mar;16(2):70-7. doi: 10.1016/j.carrev.2015.01.002. Epub 2015 Jan 22.
4
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗对三血管病变患者的比较：SYNTAX 试验的最终五年随访结果。
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.
5
Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.冠状动脉旁路移植术与经皮冠状动脉介入治疗对多支血管病变患者长期死亡率和发病率的影响：动脉搭桥和支架时代随机临床试验的荟萃分析。
JAMA Intern Med. 2014 Feb 1;174(2):223-30. doi: 10.1001/jamainternmed.2013.12844.
6
Strategies for multivessel revascularization in patients with diabetes.多血管血运重建策略在糖尿病患者中的应用。
N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.
7
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.随机比较糖尿病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术。CARDia（糖尿病患者冠状动脉血运重建）试验的 1 年结果。
J Am Coll Cardiol. 2010 Feb 2;55(5):432-40. doi: 10.1016/j.jacc.2009.10.014.
8
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗严重冠状动脉疾病的比较
N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18.
Zotero 插件